You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Litigation Details for TAKEDA PHARMACEUTICAL COMPANY LIMITED v. NORWICH PHARMACEUTICALS, INC. (D.N.J. 2020)


✉ Email this page to a colleague

« Back to Dashboard


TAKEDA PHARMACEUTICAL COMPANY LIMITED v. NORWICH PHARMACEUTICALS, INC. (D.N.J. 2020)

Docket ⤷  Try a Trial Date Filed 2020-07-15
Court District Court, D. New Jersey Date Terminated
Cause 35:271 Patent Infringement Assigned To Stanley R. Chesler
Jury Demand Referred To Cathy L. Waldor
Patents 7,105,486; 7,223,735; 7,655,630; 7,659,253; 7,659,254; 7,662,787; 7,662,788; 7,671,030; 7,671,031; 7,674,774; 7,678,770; 7,678,771; 7,687,466; 7,687,467; 7,700,561; 7,713,936; 7,718,619; 7,723,305
Link to Docket External link to docket
Small Molecule Drugs cited in TAKEDA PHARMACEUTICAL COMPANY LIMITED v. NORWICH PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for TAKEDA PHARMACEUTICAL COMPANY LIMITED v. NORWICH PHARMACEUTICALS, INC. (D.N.J. 2020)

Date Filed Document No. Description Snippet Link To Document
2022-03-02 173 Order AND Opinion The patents are: U.S. Patent Nos. 7,105,486 (“the ’486 patent”), 7,223,735 (“the ’735 patent”), 7,…7,655,630 (“the ’630 patent”), 7,659,253 (“the ’253 patent”), No. 7,659,254 (“the ’254 patent”), 7,662,7877,662,787 (“the ’787 patent”), 7,662,788 (“the ’788 patent”), 7,671,030 (“the ’030 patent”), 7,671,031 (“the…the ’031 patent”), 7,674,774 (“the ’774 patent”), 7,678,770 (“the ’770 patent”), 7,678,771 (“the ’771…PageID: 51081 patent”), 7,687,467 (“the ’467 patent”), 7,700,561 (“the ’561 patent”), 7,713,936 (“the External link to document
2022-10-13 400 Order on Motion for Summary Judgment AND Order on Motion to Preclude . 7,105,486 (“the ’486 patent”), claim 5 of U.S. Patent No. 7,678,770, and claim 7 of U.S. Patent No…787 patent”), claim 14 of U.S. Patent No. 7,687,466 (“the ’466 patent”), claim 4 of U.S. Patent No.… 1 and 4 of U.S. Patent No. 7,655,630 (“the ’630 patent”), claim 2 of U.S. Patent No. 7,662,787 (“the…expiration of the ’735 patent would infringe claim 15 of the ’735 patent, if valid and enforceable…meets the limitation recited in claim 2 of the ’253 patent, (3) would have unit-cell parameters that External link to document
2022-12-26 483 Opinion U.S. Patent No. 7,687,466 (“the ’466 patent”), U.S. Patent No. 7,105,486 (“the ’486 patent”), U.S…filed on June 1, 2004, (now U.S. Patent No. 7,105,486), which is a continuation-in-part of Application… U.S. Patent No. 7,655,630 (“the ’630 patent”), U.S. Patent No. 7,662,787 (“the ’787 patent”), U.….S. Patent No. 7,678,770 (“the ’770 patent”), U.S. Patent No. 7,671,031 (“the ’031 patent”), U.S.…U.S. Patent No. 7,223,735 (“the ’735 patent”), U.S. Patent No. 7,700,561 (“the ’561 patent”), and External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.